Moriuchi Yuko, Fuchigami Tatsuo, Horie Mio, Yamada Ryutaro, Morioka Ichiro
Pediatrics, IMS Fujimi General Hospital, Saitama, JPN.
Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, JPN.
Cureus. 2023 Mar 1;15(3):e35671. doi: 10.7759/cureus.35671. eCollection 2023 Mar.
In recent years, some cases of central precocious puberty (CPP) have been reported in patients with autism spectrum disorder (ASD). Here, we report CPP in two girls with ASD. The first case was a girl, 7 years and 9 months of age. Breast budding was observed at 7 years and 2 months and pubic hair at 7 years and 8 months of age. She was diagnosed with CPP based on guidelines and ASD according to her developmental history. Considering the psychosocial burden caused by the discrepancy between her cognitive and behavioral development and the progression of secondary sex characteristics, gonadotropin-releasing hormone (GnRH) analog therapy was initiated. Case 2 was a girl, 9 years and 8 months of age. She was diagnosed with ASD according to her developmental history. Treatment using oral aripiprazole for hypersensitivity to touch and taste had been initiated, with the onset of menarche at 9 years and 10 months of age. Breast budding had been observed before 7 years and 6 months old. She was diagnosed with CPP based on guidelines. Considering that menarche was not a significant psychosocial burden and the difficulty for her and her family to attend regular follow-ups, GnRH analog therapy was not initiated. Although the pathophysiological pathway linking ASD and CPP remains to be elucidated clinically, attention to CPP in ASD is needed, considering the increase in reported cases. In addition, the indication of GnRH analog therapy should be judged considering the psychosocial burden associated with secondary sexual characteristics.
近年来,自闭症谱系障碍(ASD)患者中报告了一些中枢性性早熟(CPP)病例。在此,我们报告两例患有ASD的女孩的CPP病例。第一例是一名7岁9个月大的女孩。7岁2个月时观察到乳房发育,7岁8个月时出现阴毛。根据指南她被诊断为CPP,并根据其发育史诊断为ASD。考虑到她认知和行为发育与第二性征进展之间的差异所带来的心理社会负担,开始了促性腺激素释放激素(GnRH)类似物治疗。病例2是一名9岁8个月大的女孩。根据其发育史她被诊断为ASD。因对触摸和味觉过敏开始使用口服阿立哌唑治疗,9岁10个月时初潮。7岁6个月前观察到乳房发育。根据指南她被诊断为CPP。考虑到初潮并非重大的心理社会负担,以及她和家人难以定期随访,未开始GnRH类似物治疗。尽管临床上ASD与CPP之间的病理生理途径仍有待阐明,但鉴于报告病例的增加,需要关注ASD中的CPP。此外,应考虑与第二性征相关的心理社会负担来判断GnRH类似物治疗的适应证。